WesBanco Bank’s Haemonetics HAE Stock Holding History

WesBanco Bank’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	25,500 +9,400	+58%	+$604K	0.05%	277
2026 Q1	$907K	Buy	+16,100	New	+$1.05M	0.03%	386
2014 Q1	–	Sell	-9,900	Closed	-$417K	–	531
2013 Q4	$417K	Sell	9,900 -2,675	-21%	-$110K	0.02%	357
2013 Q3	$501K	Sell	12,575 -1,275	-9%	-$53.5K	0.03%	320
2013 Q2	$573K	Buy	+13,850	New	+$561K	0.04%	297

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WesBanco Bank's HAE Position: Q2 2026 in Review

WesBanco Bank increased its Haemonetics (HAE) stake by 58% in Q2 2026, buying an estimated $604K and bringing the position to 25,500 shares worth $1.91M. The position accounts for 0.05% of the portfolio, ranked #277.

WesBanco Bank first reported a position in HAE in Q2 2013 and has held it in 5 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

WesBanco Bank held 25,500 shares of Haemonetics worth $1.91M as of Q2 2026.
WesBanco Bank bought 9,400 Haemonetics shares in Q2 2026, an estimated $604K.
Haemonetics made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #277 holding.
WesBanco Bank first reported a position in Haemonetics in Q2 2013 and has held it in 5 quarters since.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.